Multi-omic serum analysis reveals ferroptosis pathways and diagnostic molecular signatures associated with Moyamoya diseases
Open Access
- 29 April 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 22 (1) , 1-20
Abstract
Moyamoya disease (MMD) is a rare cerebrovascular disease in humans. Although early revascularization can improve symptoms, it cannot reverse the progression of the disease. The current diagnosis still relies on traditional a Digital Subtraction Angiography (DSA) examination, which is invasive and expensive, leading to delayed diagnosis and affecting treatment timing and patient prognosis. The ability to diagnose MMD early and develop personalized treatment plans can significantly improve the prognosis of patients. Here, we have introduced the research on MMD biomarkers. By integrating proteomics and metabolomics data, we have successfully identified over 1700 features from more than 60 serum samples collected at the onset of symptoms in MMD patients. We use multiple computational strategies to interpret complex information in serum, providing a comprehensive perspective for early diagnosis of MMD. Diagnostic ability of our biomarker is significantly better than previous studies, especially when used in combination. In the study of molecular mechanisms, we found that the ferroptosis pathway was significant disruption in MMD patients, which was also confirmed by transcriptomics data. Finally, we validated the metabolites and proteins associated with ferroptosis pathways, as well as the biomarkers screened by machine learning, using another independent MMD cohort. Our research provides important clues for the diagnosis of MMD, and this assay can identify MMD early, thereby promoting stronger monitoring and intervention.Keywords
Funding Information
- National Natural Science Foundation of China (82171280 and 82201451)
This publication has 65 references indexed in Scilit:
- Proteomic and metabolomic characterizations of moyamoya disease patient seraBrain and Behavior, 2023
- Targeted metabolomics analysis of serum amino acid profiles in patients with Moyamoya diseaseAmino Acids, 2021
- Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's diseaseAlzheimer's & Dementia, 2021
- The ring finger protein 213 gene (Rnf213) contributes to Rift Valley fever resistance in miceMammalian Genome, 2021
- WGCNA Application to Proteomic and Metabolomic Data Analysis2017
- Thymosin Beta 42016
- Inhibitory glutamate receptor channelsMolecular Neurobiology, 1996
- Bagging predictorsMachine Learning, 1996
- Physiological and pathophysiological roles of excitatory amino acids during central nervous system developmentBrain Research Reviews, 1990
- Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin β4 levels in patients with inflammatory bowel diseaseClinical Immunology and Immunopathology, 1988